Breadcrumb
- Home
- IDDI Workstreams & Task Forces
- PAH-ICON: International Consortium For Genetic Stu...
PAH-ICON: International Consortium for Genetic Studies in PAH
PAH-ICON – the International Consortium for the Genetics of Pulmonary Arterial Hypertension (PAH-ICON) is a global consortium uniting basic and clinical science experts to advance PH research through genetics and genomics. By building larger, more diverse international multidimensional datasets, the group enables collaborative studies designed to address critical unmet needs in patient care.
Aims & Goals:
The goals of PAH-ICON are to:
- work towards a molecular classification of PAH
- provide a platform for whole genome/exome sequencing and analysis at centres with the capability/facilities/resources to undertake this
- share genetic data and analysis approaches
- publish definitive high-impact publications of these studies as a Consortium
- share best practices in ethics and feedback on pertinent genetic findings to patients and relatives
There are active working groups focusing on topics including:
- Clinical genetics - ClinGen PH Gene and Variant Curation Expert Panel
- International patient advocacy and research initiatives, like TBX4life
- Standardisation and harmonisation of phenotypes and endotypes
- Exploring and pioneering sample and data sharing strategies across boundaries
- Twin studies
The Task Force meets monthly by Zoom, alternating between scientific presentations and business meetings. If you’re interested in joining this Task Force, please get in touch.
Events
-
6th Symposium of the International Consortium for Genetic Studies in P(A)H
The group held it's 6th symposium at PVRI 2026 Dublin, featuring 3 keynote presentations alongside discussion, brainstorming and networking.
Publications and achievements:
- Welch, C. L., Aldred, M. A., Balachandar, S., Dooijes, D., Eichstaedt, C. A., et al. (2023). 'Defining the clinical validity of genes reported to cause pulmonary arterial hypertension'. Genetics in Medicine, 25(11), 100925.
- Eichstaedt, C. A., Belge, C., Chung, W. K., Gräf, S., Grünig, E., et al. (2023). 'Genetic counselling and testing in pulmonary arterial hypertension: a consensus Statement on behalf of the International Consortium for Genetic Studies in PAH'. European Respiratory Journal, 61(2), 2201471.
- TBX4 life, Eric Austin, Matina Prapa
- ClinGen, a National Institutes of Health (NIH) funded resource dedicated to building a central resource that defines the clinical relevance of genes and variants for use in precision medicine and research.
Leaders
IDDI Workstreams and Task Forces
Want to get involved?
If you’re a basic or clinician scientist interested in P(A)H genetics, we would love to hear from you.
“Only international collaborations capable of generating thousands of samples from patients with idiopathic and heritable PAH will have the power to help answer the major questions on the role of genetic variation in disease penetrance, phenotype and the clinical course of disease.”
Want to be part of something special?
All PVRI members are welcome to join an IDDI Workstream or a Task Force.
Our Regional Task Forces don't yet have global coverage. If you're interested in starting one, please contact us.
2025–26 IDDI Workstream & Task Forces Report
PVRI’s latest report highlights how global IDDI Workstreams and Task Forces are accelerating progress in pulmonary hypertension research, care, and innovation. Discover key achievements from across regions and specialties.
Interested in accessing global data on PH patient experience?
Almost 4,000 patients and carers across 85 countries completed Phase 1 of our PH Global Patient Survey (PHGPS). Questions across all PH groups included diagnostic tests & timelines, genetic testing, treatments, financial burdens, hospital visits, research participation, quality of life, telemedicine, patient-reported outcome measures, and self-monitoring with digital technology. The findings have the potential to improve patient care, guide future research and help us address unmet needs.